China SXT Pharmaceuticals, Inc. Increase (Decrease) in Accounts Payable
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-07-01
| Period end | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|
| 2026-03-31 | -$693.48K 20-F · filed 2026-07-01 | |
| 2025-09-30 | -$645.53K 6-K · filed 2025-12-31 | |
| 2025-03-31 | -$114.08K 20-F · filed 2026-07-01 | |
| 2024-09-30 | $329.78K 6-K · filed 2025-12-31 | |
| 2024-03-31 | -$29.25K 20-F · filed 2026-07-01 | |
| 2023-09-30 | $19.35K 6-K · filed 2025-03-28 | |
| 2023-03-31 | $9.70K 20-F · filed 2025-07-31 | |
| 2022-03-31 | -$22.79K 20-F · filed 2024-08-13 | |
| 2020-03-31 | $302.27K 20-F · filed 2020-07-31 | |
| 2019-09-30 | $389.51K 6-K/A · filed 2020-05-22 | |
| 2019-03-31 | -$567.31K 20-F · filed 2020-07-31 | |
| 2018-09-30 | -$213.64K 6-K/A · filed 2020-05-22 | |
| 2018-03-31 | $966.57K 20-F · filed 2020-07-31 | |
| 2017-03-31 | -$1.47M 20-F · filed 2019-08-15 |